The GES self-help guide itself is very instructive as to the type of patients envisioned by the clinicians/researchers
http://www.wolfson.qmul.ac.uk/images/pdfs/getset/GET guide booklet version 1 22062010.pdf (This is the booklet given to the patients who took part in the GES arm of the trial.)
Here’s what “Julie” (see p.11 of booklet) can do in a week (after she’s stabilised her boom-bust pattern, before she starts exercising):
Works 10am-6pm Mon –Fri
Walks for 20 mins 4 days a week, a yoga class once a week, a walk with friends once a week, and shopping once a week
Goes out after work on a Thursday night for 3 hours
Goes out on a Saturday night for 2 hours
Does housework and ironing in 3x 1 hour slots at the weekend
Studies for just shy of 4 hours spread out over the week
Lucky Julie is allowed to lie in till 8am at the weekend, and after her shower and breakfast she’s rewarded with an hour of housework on Saturday and nearly two hours of study on Sunday.
On Friday evening, after her full working week and having been out the night before, Julie is allowed to cook/eat for an hour and then, I kid you not, she studies for an hour. On Friday evening.
We learn less about "Joe" (see p.20-21 of booklet), but his goal is to build up to being able to walk for 30mins so that he can go to the High Street and return with two small bags. He then “has had a busy time recently, with family staying and a few late nights, which has caused an increase in his symptoms that could be classed as a CFS/ME related setback”. His setback can’t be too worrying, since options in his setback plan include to continue his current level of exercise “even though this will feel more difficult” or knock 3 mins off his walking time.
I find it concerning that clinicians might consider this level of activity feasible for most patients, when I think this is far from being the case.
I’m also concerned that the intervention seems to be envisioned for high-functioning patients with boom and bust patterns, but is being recommended for all. Clinically very problematic. It would explain why even in this trial, whose sample could not be considered representative of the ME/CFS population, 85% of patients in this study saw minimal change in their "CFS" after GES, and only 14% reported a positive change in their "CFS", just 8% more than the "control" group (table 6).
Julie's scheduled to be shopping right now. I wonder will she bump into Joe and his two bags on the High Street?